Interim Results Statement for the six-month period ended 31 December 2017

Interim Results Statement for the six-month period ended 31 December 2017

Oxford, UK, 19 February 2018: The Board of Physiomics Plc, a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry (AIM: PYC), today announces its financial results for the six months ended 31 December 2017.

Please click here to read in full